World shares slide following an AI-led retreat on Wall Street
BANGKOK (AP) — World shares were mostly lower on Friday, with Tokyo’s Nikkei 225 losing 4% as heavy…
Hundreds of economists say ‘we must act now’ on AI’s economic impact
SAN FRANCISCO (AP) — Hundreds of economists say in an open letter that institutions “must act now” to…
Massive AI buildout poses latest inflation threat as consumers pay more for laptops and electricity
WASHINGTON — American consumers — and the Federal Reserve — are being hit with another high-cost headache .…
Why Micron Technology (MU) Is Securing Long-Term AI Memory Demand With $22 Billion in Customer Commitments
Micron Technology, Inc. (NASDAQ:MU) is one of the best performing AI stocks over the last 3 years, with…
European Medicines Agency Expedites Assessment of Revolution Medicines’ Daraxonrasib Under Phased Review Process
Revolution Medicines, Inc. REDWOOD CITY, Calif., July 07, 2026 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a…
Nearly 1 million bottles of heart, kidney medications recalled nationwide over ‘foreign substance’
Testing that raised concerns about possible foreign contamination has triggered a recall in the United States of nearly…
Revolution Medicines Presents Phase 1/2 Clinical Data for Zoldonrasib Combination Regimens in Patients with RAS G12D Metastatic Pancreatic Cancer at ESMO Gastrointestinal Cancers Congress 2026
Revolution Medicines, Inc. REDWOOD CITY, Calif., July 02, 2026 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a…
OpenAI film, dropped by Amazon, is acquired by Neon
NEW YORK (AP) — “Artificial,” Luca Guadagnino’s starry film about Sam Altman and OpenAI, has been acquired by…
Moleculin Reports Positive Phase 2/3 MIRACLE Interim Results, With Annamycin Complete Remission Rates 3-fold Greater than Control
Moleculin Biotech, Inc. Moleculin Biotech, Inc. INTERIM EFFICACY – N=45 INTENT TO TREAT (ITT) Both Annamycin dose arms…
Unicycive Therapeutics Receives Complete Response Letter
— Complete Response Letter relates to deficiencies previously identified at third-party manufacturing vendor — — FDA inspection of…
Bioness Medical Announces 510(k) Clearance for PoNS® (Portable Neuromodulation Stimulator) to Manage Patients Recovering from Stroke
First non-invasive, orally applied neuromodulation device FDA-cleared for stroke rehabilitation, expanding access for the more than 7 million…
ServiceNow (NOW) and IBM Announce Expanded Collaboration
ServiceNow, Inc. (NYSE:NOW) is one of the best trending AI stocks to watch in 2026. ServiceNow, Inc. (NYSE:NOW)…